Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDRH WOULD DESIGNATE STAFFER TO SPEED SUPPLEMENT REVIEWS UNDER KENNEDY AMENDMENT ADOPTED AT MARK-UP; THIRD-PARTY REVIEW LANGUAGE UNCHANGED

This article was originally published in The Gray Sheet

Executive Summary

FDA's device, drug, biologics and veterinary medicine centers each would be required to designate a staffer responsible for expediting supplemental applications for approved products under an amendment by Sen. Edward Kennedy (D-Mass.) incorporated into the Senate FDA reform bill (S 830) during June 18 mark-up by the Senate Labor and Human Resources Committee.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008244

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel